サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1801668

結核ワクチン治療の世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)

Global Tuberculosis Vaccine Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

出版日
発行
QYResearch
ページ情報
英文 93 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
結核ワクチン治療の世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)
出版日: 2025年09月02日
発行: QYResearch
ページ情報: 英文 93 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、結核ワクチン治療 (Tuberculosis Vaccine Treatment) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場の事業概要

  • 結核ワクチン治療 製品範囲
  • 結核ワクチン治療 タイプ別
    • 世界の結核ワクチン治療 販売：タイプ別 (2020 & 2024 & 2031)
    • Immune Vaccine
    • Therapy Vaccine
  • 結核ワクチン治療 用途別
    • 世界の結核ワクチン治療 売上 比較：用途別 (2020 & 2024 & 2031)
    • Self-Procurement
    • UNICEF
    • Other
  • 世界の結核ワクチン治療 市場 推定および予測 (2020-2031)
    • 世界の結核ワクチン治療 市場規模 in 価格 成長率 (2020-2031)
    • Global Tuberculosis Vaccine Treatment Market Size in Volume Growth Rate (2020-2031)
    • Global Tuberculosis Vaccine Treatment Price Trends (2020-2031)
  • 前提条件と制限

第2章 市場規模と予測：地域別

  • 世界の結核ワクチン治療 市場規模：地域別: 2020 VS 2024 VS 2031
  • 世界の結核ワクチン治療 過去の市場分析：地域別 (2020-2025)
    • 世界の結核ワクチン治療の販売市場シェア 地域別 (2020-2025)
    • 世界の結核ワクチン治療の収益市場シェア 地域別 (2020-2025)
  • 世界の結核ワクチン治療 市場 推定および予測 地域別 (2026-2031)
    • 世界の結核ワクチン治療 売上予測・予想 地域別 (2026-2031)
    • 世界の結核ワクチン治療の収益予測：地域別 (2026-2031)
  • 主要地域と新興市場分析
    • 北米の結核ワクチン治療 市場規模および予測 (2020-2031)
    • 欧州の結核ワクチン治療 市場規模および予測 (2020-2031)
    • 日本の結核ワクチン治療 市場規模および予測 (2020-2031)
    • 中国の結核ワクチン治療 市場規模および予測 (2020-2031)
    • インド 結核ワクチン治療 市場規模および予測 (2020-2031)

第3章 世界の市場規模：タイプ別

  • 世界の結核ワクチン治療の過去の市場概要：タイプ別 (2020-2025)
    • 世界の結核ワクチン治療 販売：タイプ別 (2020-2025)
    • 世界の結核ワクチン治療 収益：タイプ別 (2020-2025)
    • 世界の結核ワクチン治療 価格：タイプ別 (2020-2025)
  • 世界の結核ワクチン治療の市場 推定および予測：タイプ別 (2026-2031)
    • 世界の結核ワクチン治療の販売予測：タイプ別 (2026-2031)
    • 世界の結核ワクチン治療の収益予測：タイプ別 (2026-2031)
    • 世界の結核ワクチン治療の価格予測：タイプ別 (2026-2031)
  • 各種タイプ 結核ワクチン治療 代表的な企業

第4章 世界の市場規模：用途別

  • 世界の結核ワクチン治療の過去の市場概要：用途別 (2020-2025)
    • 世界の結核ワクチン治療 販売：用途別 (2020-2025)
    • 世界の結核ワクチン治療 収益：用途別 (2020-2025)
    • 世界の結核ワクチン治療 価格：用途別 (2020-2025)
  • 世界の結核ワクチン治療 市場 推定および予測：用途別 (2026-2031)
    • 世界の結核ワクチン治療の販売予測：用途別 (2026-2031)
    • 世界の結核ワクチン治療の収益予測：用途別 (2026-2031)
    • 世界の結核ワクチン治療の価格予測：用途別 (2026-2031)
  • 新たな成長源 結核ワクチン治療 アプリケーション

第5章 競合他社の状況

  • 世界の結核ワクチン治療 売上 ：競合別 (2020-2025)
  • 世界の結核ワクチン治療の上位企業：収益別 (2020-2025)
  • 世界の結核ワクチン治療の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3) & (収益ベース 結核ワクチン治療 2024年)
  • 世界の結核ワクチン治療 企業別平均価格 (2020-2025)
  • 世界の主要メーカー 結核ワクチン治療, 製造拠点 & 本社
  • 世界の主要メーカー 結核ワクチン治療, 製品の種類・用途
  • 世界の主要メーカー 結核ワクチン治療, 業界参入時期
  • 企業のM&A, 拡張計画

第6章 地域分析

  • 北米の市場: 参入企業、セグメント、下流、主要顧客
    • 北米の結核ワクチン治療 売上：企業別
    • 北米の結核ワクチン治療 売上 内訳 タイプ別 (2020-2025)
    • 北米の結核ワクチン治療 売上構成比：用途別 (2020-2025)
    • 北米の結核ワクチン治療 主要顧客
    • 北米の市場 トレンドと機会
  • 欧州の市場: 参入企業、セグメント、下流、主要顧客
    • 欧州の結核ワクチン治療 売上：企業別
    • 欧州の結核ワクチン治療 売上 内訳 タイプ別 (2020-2025)
    • 欧州の結核ワクチン治療 売上構成比：用途別 (2020-2025)
    • 欧州の結核ワクチン治療 主要顧客
    • 欧州の市場 トレンドと機会
  • 日本の市場: 参入企業、セグメント、下流、主要顧客
    • 日本の結核ワクチン治療 売上：企業別
    • 日本の結核ワクチン治療 売上 内訳 タイプ別 (2020-2025)
    • 日本の結核ワクチン治療 売上構成比：用途別 (2020-2025)
    • 日本の結核ワクチン治療 主要顧客
    • 日本の市場 トレンドと機会
  • 中国の市場: 参入企業、セグメント、下流、主要顧客
    • 中国の結核ワクチン治療 売上：企業別
    • 中国の結核ワクチン治療 売上 内訳 タイプ別 (2020-2025)
    • 中国の結核ワクチン治療 売上構成比：用途別 (2020-2025)
    • 中国の結核ワクチン治療 主要顧客
    • 中国の市場 トレンドと機会
  • インド 市場: 参入企業、セグメント、下流、主要顧客
    • インド 結核ワクチン治療 売上：企業別
    • インド 結核ワクチン治療 売上 内訳 タイプ別 (2020-2025)
    • インド 結核ワクチン治療 売上構成比：用途別 (2020-2025)
    • インド 結核ワクチン治療 主要顧客
    • インド 市場 トレンドと機会

第7章 企業概要と主要企業

  • Merck
  • Japan BCG Lab
  • Serum Institute of India
  • AJ Vaccines
  • BioFarma
  • GreenSignal Bio Pharma
  • China National Biotec
  • Biomed Lublin
  • Taj Pharmaceuticals
  • Ataulpho de Paiva
  • IVAC
  • Queen Saovabha Mem. Inst
  • Microgen

第8章 結核ワクチン治療 製造コスト分析

  • 結核ワクチン治療 主要原材料の分析
    • 主要原材料
    • 原材料の主な調達先
  • 製造コスト構成比
  • 製造工程分析： 結核ワクチン治療
  • 結核ワクチン治療 産業チェーン分析

第9章 マーケティングチャネル, 販売店と顧客

  • マーケティングチャネル
  • 結核ワクチン治療 販売代理店一覧
  • 結核ワクチン治療 顧客

第10章 結核ワクチン治療 市場動向

  • 結核ワクチン治療 業界動向
  • 結核ワクチン治療 市場の促進要因
  • 結核ワクチン治療 市場の課題
  • 結核ワクチン治療 市場の抑制要因

第11章 市場調査結果と結論

第12章 付録

図表

List of Tables

Table 1. Global Tuberculosis Vaccine Treatment Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Tuberculosis Vaccine Treatment Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Tuberculosis Vaccine Treatment Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Tuberculosis Vaccine Treatment Sales (K Dose) by Region (2020-2025)

Table 5. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2020-2025)

Table 6. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Tuberculosis Vaccine Treatment Revenue Share by Region (2020-2025)

Table 8. Global Tuberculosis Vaccine Treatment Sales (K Dose) Forecast by Region (2026-2031)

Table 9. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Tuberculosis Vaccine Treatment Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Tuberculosis Vaccine Treatment Revenue Share Forecast by Region (2026-2031)

Table 12. Global Tuberculosis Vaccine Treatment Sales by Type (K Dose) & (2020-2025)

Table 13. Global Tuberculosis Vaccine Treatment Sales Share by Type (2020-2025)

Table 14. Global Tuberculosis Vaccine Treatment Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Tuberculosis Vaccine Treatment Price by Type (USD/K Dose) & (2020-2025)

Table 16. Global Tuberculosis Vaccine Treatment Sales by Type (K Dose) & (2026-2031)

Table 17. Global Tuberculosis Vaccine Treatment Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Tuberculosis Vaccine Treatment Price by Type (USD/K Dose) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Tuberculosis Vaccine Treatment Sales by Application (K Dose) & (2020-2025)

Table 21. Global Tuberculosis Vaccine Treatment Sales Share by Application (2020-2025)

Table 22. Global Tuberculosis Vaccine Treatment Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Tuberculosis Vaccine Treatment Price by Application (USD/K Dose) & (2020-2025)

Table 24. Global Tuberculosis Vaccine Treatment Sales by Application (K Dose) & (2026-2031)

Table 25. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Tuberculosis Vaccine Treatment Price by Application (USD/K Dose) & (2026-2031)

Table 27. New Sources of Growth in Tuberculosis Vaccine Treatment Application

Table 28. Global Tuberculosis Vaccine Treatment Sales by Company (K Dose) & (2020-2025)

Table 29. Global Tuberculosis Vaccine Treatment Sales Share by Company (2020-2025)

Table 30. Global Tuberculosis Vaccine Treatment Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Tuberculosis Vaccine Treatment Revenue Share by Company (2020-2025)

Table 32. Global Tuberculosis Vaccine Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Treatment as of 2024)

Table 33. Global Market Tuberculosis Vaccine Treatment Average Price by Company (USD/K Dose) & (2020-2025)

Table 34. Global Key Manufacturers of Tuberculosis Vaccine Treatment, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Tuberculosis Vaccine Treatment, Product Type & Application

Table 36. Global Key Manufacturers of Tuberculosis Vaccine Treatment, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Tuberculosis Vaccine Treatment Sales by Company (2020-2025) & (K Dose)

Table 39. North America Tuberculosis Vaccine Treatment Sales Market Share by Company (2020-2025)

Table 40. North America Tuberculosis Vaccine Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Tuberculosis Vaccine Treatment Revenue Market Share by Company (2020-2025)

Table 42. North America Tuberculosis Vaccine Treatment Sales by Type (2020-2025) & (K Dose)

Table 43. North America Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)

Table 44. North America Tuberculosis Vaccine Treatment Sales by Application (2020-2025) & (K Dose)

Table 45. North America Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2025)

Table 46. Europe Tuberculosis Vaccine Treatment Sales by Company (2020-2025) & (K Dose)

Table 47. Europe Tuberculosis Vaccine Treatment Sales Market Share by Company (2020-2025)

Table 48. Europe Tuberculosis Vaccine Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Company (2020-2025)

Table 50. Europe Tuberculosis Vaccine Treatment Sales by Type (2020-2025) & (K Dose)

Table 51. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)

Table 52. Europe Tuberculosis Vaccine Treatment Sales by Application (2020-2025) & (K Dose)

Table 53. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2025)

Table 54. Japan Tuberculosis Vaccine Treatment Sales by Company (2020-2025) & (K Dose)

Table 55. Japan Tuberculosis Vaccine Treatment Sales Market Share by Company (2020-2025)

Table 56. Japan Tuberculosis Vaccine Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 57. Japan Tuberculosis Vaccine Treatment Revenue Market Share by Company (2020-2025)

Table 58. Japan Tuberculosis Vaccine Treatment Sales by Type (2020-2025) & (K Dose)

Table 59. Japan Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)

Table 60. Japan Tuberculosis Vaccine Treatment Sales by Application (2020-2025) & (K Dose)

Table 61. Japan Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2025)

Table 62. China Tuberculosis Vaccine Treatment Sales by Company (2020-2025) & (K Dose)

Table 63. China Tuberculosis Vaccine Treatment Sales Market Share by Company (2020-2025)

Table 64. China Tuberculosis Vaccine Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 65. China Tuberculosis Vaccine Treatment Revenue Market Share by Company (2020-2025)

Table 66. China Tuberculosis Vaccine Treatment Sales by Type (2020-2025) & (K Dose)

Table 67. China Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)

Table 68. China Tuberculosis Vaccine Treatment Sales by Application (2020-2025) & (K Dose)

Table 69. China Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2025)

Table 70. India Tuberculosis Vaccine Treatment Sales by Company (2020-2025) & (K Dose)

Table 71. India Tuberculosis Vaccine Treatment Sales Market Share by Company (2020-2025)

Table 72. India Tuberculosis Vaccine Treatment Revenue by Company (2020-2025) & (US$ Million)

Table 73. India Tuberculosis Vaccine Treatment Revenue Market Share by Company (2020-2025)

Table 74. India Tuberculosis Vaccine Treatment Sales by Type (2020-2025) & (K Dose)

Table 75. India Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)

Table 76. India Tuberculosis Vaccine Treatment Sales by Application (2020-2025) & (K Dose)

Table 77. India Tuberculosis Vaccine Treatment Sales Market Share by Application (2020-2025)

Table 78. Merck Company Information

Table 79. Merck Description and Business Overview

Table 80. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 81. Merck Tuberculosis Vaccine Treatment Product

Table 82. Merck Recent Development

Table 83. Japan BCG Lab Company Information

Table 84. Japan BCG Lab Description and Business Overview

Table 85. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 86. Japan BCG Lab Tuberculosis Vaccine Treatment Product

Table 87. Japan BCG Lab Recent Development

Table 88. Serum Institute of India Company Information

Table 89. Serum Institute of India Description and Business Overview

Table 90. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 91. Serum Institute of India Tuberculosis Vaccine Treatment Product

Table 92. Serum Institute of India Recent Development

Table 93. AJ Vaccines Company Information

Table 94. AJ Vaccines Description and Business Overview

Table 95. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 96. AJ Vaccines Tuberculosis Vaccine Treatment Product

Table 97. AJ Vaccines Recent Development

Table 98. BioFarma Company Information

Table 99. BioFarma Description and Business Overview

Table 100. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 101. BioFarma Tuberculosis Vaccine Treatment Product

Table 102. BioFarma Recent Development

Table 103. GreenSignal Bio Pharma Company Information

Table 104. GreenSignal Bio Pharma Description and Business Overview

Table 105. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 106. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product

Table 107. GreenSignal Bio Pharma Recent Development

Table 108. China National Biotec Company Information

Table 109. China National Biotec Description and Business Overview

Table 110. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 111. China National Biotec Tuberculosis Vaccine Treatment Product

Table 112. China National Biotec Recent Development

Table 113. Biomed Lublin Company Information

Table 114. Biomed Lublin Description and Business Overview

Table 115. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 116. Biomed Lublin Tuberculosis Vaccine Treatment Product

Table 117. Biomed Lublin Recent Development

Table 118. Taj Pharmaceuticals Company Information

Table 119. Taj Pharmaceuticals Description and Business Overview

Table 120. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 121. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product

Table 122. Taj Pharmaceuticals Recent Development

Table 123. Ataulpho de Paiva Company Information

Table 124. Ataulpho de Paiva Description and Business Overview

Table 125. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 126. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product

Table 127. Ataulpho de Paiva Recent Development

Table 128. IVAC Company Information

Table 129. IVAC Description and Business Overview

Table 130. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 131. IVAC Tuberculosis Vaccine Treatment Product

Table 132. IVAC Recent Development

Table 133. Queen Saovabha Mem. Inst Company Information

Table 134. Queen Saovabha Mem. Inst Description and Business Overview

Table 135. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 136. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product

Table 137. Queen Saovabha Mem. Inst Recent Development

Table 138. Microgen Company Information

Table 139. Microgen Description and Business Overview

Table 140. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2020-2025)

Table 141. Microgen Tuberculosis Vaccine Treatment Product

Table 142. Microgen Recent Development

Table 143. Production Base and Market Concentration Rate of Raw Material

Table 144. Key Suppliers of Raw Materials

Table 145. Tuberculosis Vaccine Treatment Distributors List

Table 146. Tuberculosis Vaccine Treatment Customers List

Table 147. Tuberculosis Vaccine Treatment Market Trends

Table 148. Tuberculosis Vaccine Treatment Market Drivers

Table 149. Tuberculosis Vaccine Treatment Market Challenges

Table 150. Tuberculosis Vaccine Treatment Market Restraints

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Tuberculosis Vaccine Treatment Product Picture

Figure 2. Global Tuberculosis Vaccine Treatment Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Tuberculosis Vaccine Treatment Sales Market Share by Type in 2024 & 2031

Figure 4. Immune Vaccine Product Picture

Figure 5. Therapy Vaccine Product Picture

Figure 6. Global Tuberculosis Vaccine Treatment Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Tuberculosis Vaccine Treatment Sales Market Share by Application in 2024 & 2031

Figure 8. Self-Procurement Examples

Figure 9. UNICEF Examples

Figure 10. Other Examples

Figure 11. Global Tuberculosis Vaccine Treatment Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Tuberculosis Vaccine Treatment Sales Growth Rate (2020-2031) & (US$ Million)

Figure 13. Global Tuberculosis Vaccine Treatment Sales (K Dose) Growth Rate (2020-2031)

Figure 14. Global Tuberculosis Vaccine Treatment Price Trends Growth Rate (2020-2031) & (USD/K Dose)

Figure 15. Tuberculosis Vaccine Treatment Report Years Considered

Figure 16. Global Market Tuberculosis Vaccine Treatment Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 17. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Tuberculosis Vaccine Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. North America Tuberculosis Vaccine Treatment Sales (K Dose) Growth Rate (2020-2031)

Figure 20. Europe Tuberculosis Vaccine Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Europe Tuberculosis Vaccine Treatment Sales (K Dose) Growth Rate (2020-2031)

Figure 22. Japan Tuberculosis Vaccine Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. Japan Tuberculosis Vaccine Treatment Sales (K Dose) Growth Rate (2020-2031)

Figure 24. China Tuberculosis Vaccine Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. China Tuberculosis Vaccine Treatment Sales (K Dose) Growth Rate (2020-2031)

Figure 26. India Tuberculosis Vaccine Treatment Revenue (US$ Million) Growth Rate (2020-2031)

Figure 27. India Tuberculosis Vaccine Treatment Sales (K Dose) Growth Rate (2020-2031)

Figure 28. Global Tuberculosis Vaccine Treatment Revenue Share by Type (2020-2025)

Figure 29. Global Tuberculosis Vaccine Treatment Sales Share by Type (2026-2031)

Figure 30. Global Tuberculosis Vaccine Treatment Revenue Share by Type (2026-2031)

Figure 31. Global Tuberculosis Vaccine Treatment Revenue Share by Application (2020-2025)

Figure 32. Global Tuberculosis Vaccine Treatment Revenue Growth Rate by Application in 2020 & 2024

Figure 33. Global Tuberculosis Vaccine Treatment Sales Share by Application (2026-2031)

Figure 34. Global Tuberculosis Vaccine Treatment Revenue Share by Application (2026-2031)

Figure 35. Global Tuberculosis Vaccine Treatment Sales Share by Company (2024)

Figure 36. Global Tuberculosis Vaccine Treatment Revenue Share by Company (2024)

Figure 37. Global 5 Largest Tuberculosis Vaccine Treatment Players Market Share by Revenue in Tuberculosis Vaccine Treatment: 2020 & 2024

Figure 38. Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 39. Manufacturing Cost Structure of Tuberculosis Vaccine Treatment

Figure 40. Manufacturing Process Analysis of Tuberculosis Vaccine Treatment

Figure 41. Tuberculosis Vaccine Treatment Industrial Chain

Figure 42. Channels of Distribution (Direct Vs Distribution)

Figure 43. Distributors Profiles

Figure 44. Bottom-up and Top-down Approaches for This Report

Figure 45. Data Triangulation

Figure 46. Key Executives Interviewed

目次

This research report focuses on the Tuberculosis Vaccine Treatment Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Market Overview

  • 1.1 Tuberculosis Vaccine Treatment Product Scope
  • 1.2 Tuberculosis Vaccine Treatment by Type
    • 1.2.1 Global Tuberculosis Vaccine Treatment Sales by Type (2020 & 2024 & 2031)
    • 1.2.2 Immune Vaccine
    • 1.2.3 Therapy Vaccine
  • 1.3 Tuberculosis Vaccine Treatment by Application
    • 1.3.1 Global Tuberculosis Vaccine Treatment Sales Comparison by Application (2020 & 2024 & 2031)
    • 1.3.2 Self-Procurement
    • 1.3.3 UNICEF
    • 1.3.4 Other
  • 1.4 Global Tuberculosis Vaccine Treatment Market Estimates and Forecasts (2020-2031)
    • 1.4.1 Global Tuberculosis Vaccine Treatment Market Size in Value Growth Rate (2020-2031)
    • 1.4.2 Global Tuberculosis Vaccine Treatment Market Size in Volume Growth Rate (2020-2031)
    • 1.4.3 Global Tuberculosis Vaccine Treatment Price Trends (2020-2031)
  • 1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

  • 2.1 Global Tuberculosis Vaccine Treatment Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2 Global Tuberculosis Vaccine Treatment Retrospective Market Scenario by Region (2020-2025)
    • 2.2.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2020-2025)
    • 2.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2020-2025)
  • 2.3 Global Tuberculosis Vaccine Treatment Market Estimates and Forecasts by Region (2026-2031)
    • 2.3.1 Global Tuberculosis Vaccine Treatment Sales Estimates and Forecasts by Region (2026-2031)
    • 2.3.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2026-2031)
  • 2.4 Major Region and Emerging Market Analysis
    • 2.4.1 North America Tuberculosis Vaccine Treatment Market Size and Prospective (2020-2031)
    • 2.4.2 Europe Tuberculosis Vaccine Treatment Market Size and Prospective (2020-2031)
    • 2.4.3 Japan Tuberculosis Vaccine Treatment Market Size and Prospective (2020-2031)
    • 2.4.4 China Tuberculosis Vaccine Treatment Market Size and Prospective (2020-2031)
    • 2.4.5 India Tuberculosis Vaccine Treatment Market Size and Prospective (2020-2031)

3 Global Market Size by Type

  • 3.1 Global Tuberculosis Vaccine Treatment Historic Market Review by Type (2020-2025)
    • 3.1.1 Global Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
    • 3.1.2 Global Tuberculosis Vaccine Treatment Revenue by Type (2020-2025)
    • 3.1.3 Global Tuberculosis Vaccine Treatment Price by Type (2020-2025)
  • 3.2 Global Tuberculosis Vaccine Treatment Market Estimates and Forecasts by Type (2026-2031)
    • 3.2.1 Global Tuberculosis Vaccine Treatment Sales Forecast by Type (2026-2031)
    • 3.2.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2026-2031)
    • 3.2.3 Global Tuberculosis Vaccine Treatment Price Forecast by Type (2026-2031)
  • 3.3 Different Types Tuberculosis Vaccine Treatment Representative Players

4 Global Market Size by Application

  • 4.1 Global Tuberculosis Vaccine Treatment Historic Market Review by Application (2020-2025)
    • 4.1.1 Global Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
    • 4.1.2 Global Tuberculosis Vaccine Treatment Revenue by Application (2020-2025)
    • 4.1.3 Global Tuberculosis Vaccine Treatment Price by Application (2020-2025)
  • 4.2 Global Tuberculosis Vaccine Treatment Market Estimates and Forecasts by Application (2026-2031)
    • 4.2.1 Global Tuberculosis Vaccine Treatment Sales Forecast by Application (2026-2031)
    • 4.2.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Application (2026-2031)
    • 4.2.3 Global Tuberculosis Vaccine Treatment Price Forecast by Application (2026-2031)
  • 4.3 New Sources of Growth in Tuberculosis Vaccine Treatment Application

5 Competition Landscape by Players

  • 5.1 Global Tuberculosis Vaccine Treatment Sales by Players (2020-2025)
  • 5.2 Global Top Tuberculosis Vaccine Treatment Players by Revenue (2020-2025)
  • 5.3 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Treatment as of 2024)
  • 5.4 Global Tuberculosis Vaccine Treatment Average Price by Company (2020-2025)
  • 5.5 Global Key Manufacturers of Tuberculosis Vaccine Treatment, Manufacturing Sites & Headquarters
  • 5.6 Global Key Manufacturers of Tuberculosis Vaccine Treatment, Product Type & Application
  • 5.7 Global Key Manufacturers of Tuberculosis Vaccine Treatment, Date of Enter into This Industry
  • 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

  • 6.1 North America Market: Players, Segments, Downstream and Major Customers
    • 6.1.1 North America Tuberculosis Vaccine Treatment Sales by Company
      • 6.1.1.1 North America Tuberculosis Vaccine Treatment Sales by Company (2020-2025)
      • 6.1.1.2 North America Tuberculosis Vaccine Treatment Revenue by Company (2020-2025)
    • 6.1.2 North America Tuberculosis Vaccine Treatment Sales Breakdown by Type (2020-2025)
    • 6.1.3 North America Tuberculosis Vaccine Treatment Sales Breakdown by Application (2020-2025)
    • 6.1.4 North America Tuberculosis Vaccine Treatment Major Customer
    • 6.1.5 North America Market Trend and Opportunities
  • 6.2 Europe Market: Players, Segments, Downstream and Major Customers
    • 6.2.1 Europe Tuberculosis Vaccine Treatment Sales by Company
      • 6.2.1.1 Europe Tuberculosis Vaccine Treatment Sales by Company (2020-2025)
      • 6.2.1.2 Europe Tuberculosis Vaccine Treatment Revenue by Company (2020-2025)
    • 6.2.2 Europe Tuberculosis Vaccine Treatment Sales Breakdown by Type (2020-2025)
    • 6.2.3 Europe Tuberculosis Vaccine Treatment Sales Breakdown by Application (2020-2025)
    • 6.2.4 Europe Tuberculosis Vaccine Treatment Major Customer
    • 6.2.5 Europe Market Trend and Opportunities
  • 6.3 Japan Market: Players, Segments, Downstream and Major Customers
    • 6.3.1 Japan Tuberculosis Vaccine Treatment Sales by Company
      • 6.3.1.1 Japan Tuberculosis Vaccine Treatment Sales by Company (2020-2025)
      • 6.3.1.2 Japan Tuberculosis Vaccine Treatment Revenue by Company (2020-2025)
    • 6.3.2 Japan Tuberculosis Vaccine Treatment Sales Breakdown by Type (2020-2025)
    • 6.3.3 Japan Tuberculosis Vaccine Treatment Sales Breakdown by Application (2020-2025)
    • 6.3.4 Japan Tuberculosis Vaccine Treatment Major Customer
    • 6.3.5 Japan Market Trend and Opportunities
  • 6.4 China Market: Players, Segments, Downstream and Major Customers
    • 6.4.1 China Tuberculosis Vaccine Treatment Sales by Company
      • 6.4.1.1 China Tuberculosis Vaccine Treatment Sales by Company (2020-2025)
      • 6.4.1.2 China Tuberculosis Vaccine Treatment Revenue by Company (2020-2025)
    • 6.4.2 China Tuberculosis Vaccine Treatment Sales Breakdown by Type (2020-2025)
    • 6.4.3 China Tuberculosis Vaccine Treatment Sales Breakdown by Application (2020-2025)
    • 6.4.4 China Tuberculosis Vaccine Treatment Major Customer
    • 6.4.5 China Market Trend and Opportunities
  • 6.5 India Market: Players, Segments, Downstream and Major Customers
    • 6.5.1 India Tuberculosis Vaccine Treatment Sales by Company
      • 6.5.1.1 India Tuberculosis Vaccine Treatment Sales by Company (2020-2025)
      • 6.5.1.2 India Tuberculosis Vaccine Treatment Revenue by Company (2020-2025)
    • 6.5.2 India Tuberculosis Vaccine Treatment Sales Breakdown by Type (2020-2025)
    • 6.5.3 India Tuberculosis Vaccine Treatment Sales Breakdown by Application (2020-2025)
    • 6.5.4 India Tuberculosis Vaccine Treatment Major Customer
    • 6.5.5 India Market Trend and Opportunities

7 Company Profiles and Key Figures

  • 7.1 Merck
    • 7.1.1 Merck Company Information
    • 7.1.2 Merck Business Overview
    • 7.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.1.4 Merck Tuberculosis Vaccine Treatment Products Offered
    • 7.1.5 Merck Recent Development
  • 7.2 Japan BCG Lab
    • 7.2.1 Japan BCG Lab Company Information
    • 7.2.2 Japan BCG Lab Business Overview
    • 7.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Products Offered
    • 7.2.5 Japan BCG Lab Recent Development
  • 7.3 Serum Institute of India
    • 7.3.1 Serum Institute of India Company Information
    • 7.3.2 Serum Institute of India Business Overview
    • 7.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Products Offered
    • 7.3.5 Serum Institute of India Recent Development
  • 7.4 AJ Vaccines
    • 7.4.1 AJ Vaccines Company Information
    • 7.4.2 AJ Vaccines Business Overview
    • 7.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Products Offered
    • 7.4.5 AJ Vaccines Recent Development
  • 7.5 BioFarma
    • 7.5.1 BioFarma Company Information
    • 7.5.2 BioFarma Business Overview
    • 7.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.5.4 BioFarma Tuberculosis Vaccine Treatment Products Offered
    • 7.5.5 BioFarma Recent Development
  • 7.6 GreenSignal Bio Pharma
    • 7.6.1 GreenSignal Bio Pharma Company Information
    • 7.6.2 GreenSignal Bio Pharma Business Overview
    • 7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Products Offered
    • 7.6.5 GreenSignal Bio Pharma Recent Development
  • 7.7 China National Biotec
    • 7.7.1 China National Biotec Company Information
    • 7.7.2 China National Biotec Business Overview
    • 7.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.7.4 China National Biotec Tuberculosis Vaccine Treatment Products Offered
    • 7.7.5 China National Biotec Recent Development
  • 7.8 Biomed Lublin
    • 7.8.1 Biomed Lublin Company Information
    • 7.8.2 Biomed Lublin Business Overview
    • 7.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Products Offered
    • 7.8.5 Biomed Lublin Recent Development
  • 7.9 Taj Pharmaceuticals
    • 7.9.1 Taj Pharmaceuticals Company Information
    • 7.9.2 Taj Pharmaceuticals Business Overview
    • 7.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Products Offered
    • 7.9.5 Taj Pharmaceuticals Recent Development
  • 7.10 Ataulpho de Paiva
    • 7.10.1 Ataulpho de Paiva Company Information
    • 7.10.2 Ataulpho de Paiva Business Overview
    • 7.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Products Offered
    • 7.10.5 Ataulpho de Paiva Recent Development
  • 7.11 IVAC
    • 7.11.1 IVAC Company Information
    • 7.11.2 IVAC Business Overview
    • 7.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.11.4 IVAC Tuberculosis Vaccine Treatment Products Offered
    • 7.11.5 IVAC Recent Development
  • 7.12 Queen Saovabha Mem. Inst
    • 7.12.1 Queen Saovabha Mem. Inst Company Information
    • 7.12.2 Queen Saovabha Mem. Inst Business Overview
    • 7.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Products Offered
    • 7.12.5 Queen Saovabha Mem. Inst Recent Development
  • 7.13 Microgen
    • 7.13.1 Microgen Company Information
    • 7.13.2 Microgen Business Overview
    • 7.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2020-2025)
    • 7.13.4 Microgen Tuberculosis Vaccine Treatment Products Offered
    • 7.13.5 Microgen Recent Development

8 Tuberculosis Vaccine Treatment Manufacturing Cost Analysis

  • 8.1 Tuberculosis Vaccine Treatment Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
  • 8.4 Tuberculosis Vaccine Treatment Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Tuberculosis Vaccine Treatment Distributors List
  • 9.3 Tuberculosis Vaccine Treatment Customers

10 Tuberculosis Vaccine Treatment Market Dynamics

  • 10.1 Tuberculosis Vaccine Treatment Industry Trends
  • 10.2 Tuberculosis Vaccine Treatment Market Drivers
  • 10.3 Tuberculosis Vaccine Treatment Market Challenges
  • 10.4 Tuberculosis Vaccine Treatment Market Restraints

11 Research Findings and Conclusion

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Methodology/Research Approach
      • 12.1.1.1 Research Programs/Design
      • 12.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 12.1.2 Data Source
      • 12.1.2.1 Secondary Sources
      • 12.1.2.2 Primary Sources
  • 12.2 Author Details
  • 12.3 Disclaimer